NMRA · CIK 0001885522 · operating
Neumora Therapeutics, Inc. (NMRA) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $544 million, Neumora Therapeutics, Inc. is a small-cap company. The stock currently trades at $3.20, down 8.31% today, with a 52-week range of $0.61–$3.65.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.53 | $-1.53 | +57.9% | |
| 2023 | $-3.63 | $-3.63 | — |